Provided by American Lung Association
Survey data released today show that only 36% of people know that lung cancer screening is available and 29% know that lung cancer is the leading cancer killer of women and men. Today, the American Lung Association’s LUNG FORCE initiative released the 2021 Lung Health Barometer, as it recognizes the start of Lung Cancer Awareness Month.
“Here in Virginia and across the nation, lung cancer is the leading cancer killer. It is estimated that in 2021, 5,820 people will be diagnosed with lung cancer and 3,520 will die from the disease,” said Aleks Casper, Director of Advocacy at the Lung Association in Virginia. “However, there is hope. The five-year survival rate has increased 33% in the past 10 years thanks to advancements in treatment, research and lifesaving lung cancer screening.”
The 2021 Lung Health Barometer surveyed 4,000 Americans nationwide about lung health and lung cancer. Some key findings show that:
- 29% of Americans know that lung cancer is the leading cancer killer of women and men, which is an 8% increase from the 2020 Lung Health Barometer.
- Only 10% of adults understand that lung cancer is among the most likely cancers to affect women while 35% know that it is among those cancers most likely to affect men.
- Only 36% of respondents know that lung cancer screening is now available for early detection of the disease for those who are high risk.
Throughout Lung Cancer Awareness Month, the Lung Association will be sharing new resources, the State of Lung Cancer Report (November 16), inspiring patient stories and lifesaving lung cancer screening information. In addition, through the Lung Association’s Lung Cancer Patient Meetup on the Go program, the organization is offering several webinars and plans to share recordings of the webinars in November. Learn more at lung.org/patient-meetup.
This is the sixth year of the Lung Health Barometer, which is conducted by the Lung Association’s LUNG FORCE initiative. LUNG FORCE unites the nation to stand together for lung health and against lung cancer.